Oklahoma judge finds Johnson & Johnson liable in opioid epidemic, ordering $572 million damages
Still, J&J said it would appeal, and seek to put payment of the award on hold during the appeal process.
Oklahoma alleged that J&J’s marketing practices helped fuel the opioid epidemic by flooding the market with painkillers. The trial came after Oklahoma had resolved claims against OxyContin maker Purdue Pharma LP in March for $270 million and against Teva in May for $85 million, leaving J&J as the lone defendant.
Some plaintiffs’ lawyers have compared the opioid cases to litigation by states against the tobacco industry that led to a $246 billion settlement in 1998. The state’s lawyers called J&J an opioid “kingpin” and argued that its marketing efforts created a public nuisance as doctors over-prescribed the drugs, leading to a surge in overdose deaths in Oklahoma.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oklahoma judge finds J&J liable in opioid epidemic, orders $572 million damagesAn Oklahoma judge orders Johnson & Johnson to pay $572 million after ruling the drugmaker liable for fueling an opioid epidemic in the state by deceptively marketing painkillers
Read more »
Judge fines Johnson & Johnson $572 million for role in Oklahoma opioid caseJohnson & Johnson ordered to pay $572 million in Oklahoma opioid case
Read more »
Judge Rules Against Johnson & Johnson in Oklahoma Opioid TrialJohnson & Johnson lost a civil case in Oklahoma for their role in the opioid crisis, which could set a precedent for more than 2,000 other cases that have already been filed across the country
Read more »
Johnson & Johnson Ordered to Pay $572 Million in Oklahoma Opioid CaseJohnson & Johnson must pay $572 million for contributing to an opioid-addiction crisis in Oklahoma, a judge there ruled in a closely watched trial. The company said it would appeal the judgment.
Read more »
Johnson & Johnson must pay over $572 million for its role in Oklahoma opioid crisis, judge rulesOklahoma's attorney general claimed that the company marketed opioids to doctors while downplaying the risks of the addictive painkillers since the 1990s.
Read more »